DBI

Acyl-CoA-binding protein · P07108 · DBI on Sugi Atlas →

0 patent compounds predicted against DBI, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DBI by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate PHASE2/PHASE3WITHDRAWN
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease PHASE2COMPLETED
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC PHASE1/PHASE2UNKNOWN
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients PHASE2COMPLETED
The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Insulin Regulation of Lipolysis and Lipolysis Proteins EARLY_PHASE1RECRUITING
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease EARLY_PHASE1COMPLETED
Role of Dairy Products in Weight Maintenance nanCOMPLETED
Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors nanNOT_YET_RECRUITING
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
Epidemiology of Atherosclerosis nanCOMPLETED
The Role of Sugars in Fat Accumulation in the Liver nanRECRUITING
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study nanCOMPLETED
Systemic Biomarkers of Brain Injury From Hyperammonemia nanRECRUITING
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Myoinositol Treatment and Asprosin Levels in PCOS nanCOMPLETED
Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism nanCOMPLETED
Genetic and Environmental Determinants of Triglycerides (GOLDN) nanCOMPLETED
Plasma Mannose Associated Parameter Levels in Nondiabetic Coronary Artery Disease nanCOMPLETED
Genomic Dissection of a QTL Affecting the Lipid Profile nanWITHDRAWN
Influence of WNT4 VEZT FSHB and SIRT1 SNPs in Endometriosis: a Case Control Study of the Sardinian Population nanUNKNOWN
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events nanCOMPLETED
The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients nanUNKNOWN
Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome nanUNKNOWN
Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes nanCOMPLETED
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes nanCOMPLETED
The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a DBI binder may also engage these)

ProteinNameSimilarity
P07107 1.000 P07107 →
P12026 1.000 P12026 →
Q8WN94 1.000 Q8WN94 →
P82934 1.000 P82934 →
P31786 1.000 P31786 →
P11030 0.999 P11030 →
Q39779 0.998 Q39779 →
P42281 0.998 P42281 →
Q8N6N7 0.997 Q8N6N7 →
P45883 0.996 P45883 →
Q9TQX6 0.996 Q9TQX6 →
Q9D258 0.994 Q9D258 →
Q9PRL8 0.993 Q9PRL8 →
P61867 0.992 P61867 →
O04066 0.992 O04066 →
Q9Y7Z3 0.992 Q9Y7Z3 →
P31787 0.991 P31787 →
P0C8L7 0.991 P0C8L7 →
O01805 0.991 O01805 →
Q5VRM0 0.991 Q5VRM0 →
O22643 0.990 O22643 →
Q3SZF0 0.990 Q3SZF0 →
Q84SC3 0.990 Q84SC3 →
Q39315 0.989 Q39315 →
P57752 0.989 P57752 →
Q5FXM5 0.988 Q5FXM5 →
P61868 0.986 P61868 →
P31824 0.986 P31824 →
P56702 0.984 P56702 →
Q9MZG3 0.982 Q9MZG3 →